Gold tier: mechanically validated evidence, with its primary source.
369 evidence items · page 10 / 15
36 %Among hospitalized HIV-positive adults in West Africa who died, tuberculosis was the most frequent fatal disease, occurring in 36% of deaths.
Côte d'Ivoiretuberculose · VIH/sidaobserved 2010published 2014Journal of the International AIDS Societyeurope_pmcdocument of 22 observationsDOI 10.7448/ias.17.1.18797
755 participantsAt baseline, 755 participants initiated antiretroviral therapy in the Temprano randomized trial in Abidjan.
Côte d'IvoireVIH/sidapublished 2016AIDS research and therapyeurope_pmcdocument of 9 observations
43.8 %Detectable HCV RNA was identified in 43.8% of anti-HCV positive HIV-2-infected patients in the IeDEA HIV-2 West Africa cohort surveyed from March to December 2012.
Côte d'Ivoirehépatite C · VIH/sidaobserved March to December 2012published 2018Journal of public health in Africaeurope_pmcdocument of 9 observations
33.7 %The estimated prevalence of HIV infection among female sex workers in Abidjan, Côte d'Ivoire was 33.7%.
Côte d'IvoireVIH/sidaobserved 2013published 2015BMC oral healtheurope_pmcdocument of 7 observations
1.66 hazard_ratioPatients aged ≥60 years had an increased risk of death in the first 36 months on ART with an adjusted hazard ratio of 1.66.
Côte d'IvoireVIH/sidapublished 2018HIV/AIDS (Auckland, N.Z.)europe_pmcdocument of 7 observations
34.2 %Tuberculosis accounted for 34.2% of AIDS-defining reasons for hospitalization.
Côte d'Ivoiretuberculose · VIH/sidapublished 2013Bulletin de la Societe de pathologie exotique (1990)europe_pmcdocument of 16 observations
No external and visible congenital malformation was observed in HIV-infected women exposed to efavirenz during pregnancy.
Côte d'IvoireVIH/sidaobserved 2003–2009published 2011Journal of acquired immune deficiency syndromes (1999)europe_pmcdocument of 9 observationsDOI 10.1097/qai.0b013e3181ff04e6
8.6 per_100_person-yearsHIV incidence among regular female blood donors in Abidjan decreased from 8.6 per 100 person-years in 1992–1994 to 0.11 per 100 person-years in 2010–2012.
Côte d'IvoireVIH/sidaobserved 1992–1994published 2018Open forum infectious diseaseseurope_pmcdocument of 12 observations
4 %HCV prevalence was 4.0% among HIV-1&2 dually reactive patients in the IeDEA HIV-2 West Africa cohort surveyed from March to December 2012.
Côte d'Ivoirehépatite C · VIH/sidaobserved March to December 2012published 2018Journal of public health in Africaeurope_pmcdocument of 9 observations
1 %1% of 1,234 new samples from the Ivory Coast, Kenya, South Africa, Thailand, and the United States were identified as elite neutralizers.
Afrique du Sud · Côte d'Ivoire · KenyaVIH/sidapublished 2009Journal of virologyeurope_pmcdocument of 2 observationsDOI 10.1128/jvi.00110-09
64 %Among HIV-infected adults interviewed, 64% could not be given any recommendation regarding early initiation of antiretroviral treatment (ART) due to either no stable partnership (30%) or being in a stable partnership with an unaware partner status (34%).
Côte d'IvoireVIH/sidapublished 2014AIDS (London, England)europe_pmcdocument of 5 observations
1.07 adjusted_IRRHBsAg-positive individuals with HBV-DNA ≥2000 IU/mL had an adjusted incidence rate ratio for mortality of 1.07 (95% CI = 0.01–4.91) at CD4+ counts >500/mm³ compared to HBsAg-negative individuals.
Côte d'Ivoirehépatite B · VIH/sidapublished 2021Antiviral therapyeurope_pmcdocument of 4 observations
90.3 %28 (90.3%) of the HIV-2 patients were on PI-based ART-regimen at enrolment.
Côte d'IvoireVIH/sidapublished 2020PloS oneeurope_pmcdocument of 13 observationsDOI 10.1371/journal.pone.0236642
All three patients had received antiretroviral therapy for more than four years, including lopinavir/ritonavir for more than eight months.
Côte d'IvoireVIH/sidapublished 2009Antiviral therapyeurope_pmcdocument of 11 observations
82.1 %82.1% of HIV-infected female sex workers in Abidjan, Côte d'Ivoire were on antiretroviral therapy.
Côte d'IvoireVIH/sidaobserved 2013published 2015BMC oral healtheurope_pmcdocument of 7 observations
245 patientsOf 245 patients followed for up to 3 years in a cohort of HIV-infected patients of sub-Saharan African origin, the incidence of metabolic syndrome, insulin resistance, and lipodystrophy was observed.
Côte d'IvoireVIH/sidapublished 2015AIDS research and human retroviruseseurope_pmcdocument of 7 observations
86.9 %Of 237 HIV-infected patients from two clinical trials, 206 (86.9%) tested positive for hepatitis B surface antigen (HBsAg) using MiniVidas® and had validated serological tests using Architect.
Côte d'Ivoirehépatite B · VIH/sidapublished 2015Diagnostic microbiology and infectious diseaseeurope_pmc
Among 791 HIV-infected patients in West Africa, HBsAg positivity was 7.9% in HIV-1 patients, 7.2% in HIV-1&2 dually reactive patients, and 9.4% in HIV-2 patients.
Côte d'Ivoirehépatite B · VIH/sidaobserved 2012published 2017BMC infectious diseaseseurope_pmcdocument of 7 observations
9.5 per_100_person_yearsIn patients with pre-ART CD4 cell count 200–349 cells/μL, incidence of severe morbidity was 9.5 per 100 person-years.
Côte d'IvoireVIH/sidapublished 2007AIDS (London, England)europe_pmcdocument of 9 observations
10 childrenThe study included 10 children and 89 adolescents victims of rape in Abidjan between 2000 and 2013.
Côte d'IvoireVIH/sidaobserved 2000-2013published 2015Medecine et maladies infectieuseseurope_pmcdocument of 3 observations
12 %Among HIV-infected adults interviewed, 12% with more than 500 CD4+ cells/μl had a seronegative partner and should be recommended antiretroviral treatment (ART).
Côte d'IvoireVIH/sidapublished 2014AIDS (London, England)europe_pmcdocument of 5 observations
21 casesAmong the 128 cases of non-occupational HIV exposure, 21 were due to occasional unprotected sex.
Côte d'IvoireVIH/sidaobserved 2000-2007published 2010Medecine et maladies infectieuseseurope_pmcdocument of 13 observations
10.5 %The prevalence of HIV at baseline was 10.5% among 489 female sex workers enrolled in the PRINCESSE cohort in Côte d'Ivoire.
Côte d'IvoireVIH/sidapublished 2025Frontiers in public healtheurope_pmcdocument of 7 observationsDOI 10.3389/fpubh.2025.1535122
13 %Among ART-naive HIV-1-infected adults in Côte d'Ivoire, 13% were HBsAg-positive.
Côte d'Ivoirehépatite B · VIH/sidapublished 2010Antiviral therapyeurope_pmcdocument of 7 observations
19.7 %At baseline, 19.7% of participants were overweight.
Côte d'IvoireVIH/sidapublished 2016AIDS research and therapyeurope_pmcdocument of 9 observations
Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.